The company has a looming opportunity to grab the booming GLP-1 agonist market by the horns.
Eli Lilly (LLY) closed the most recent trading day at $825.91, moving +0.41% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.55%. Meanwhile, the ...